Cytogenetic analysis tied to early and accurate diagnosis of primary amenorrhea, improved QoL: Study
Primary amenorrhoea, a prevalent gynecological disorder among adolescent girls, is frequently associated with chromosomal abnormalities. Recent study evaluated the various types of chromosomal abnormalities found in 40 patients diagnosed with primary amenorrhea (PA) at the Department of Genetics in Nirnayan Healthcare, Kolkata, India. Cytogenetic analysis was performed on peripheral blood samples to screen for chromosomal abnormalities. Out of the 40 PA patients, 29 (72.5%) had normal karyotypes, with 28 (70%) being 46,XX and 1 (2.5%) having a 46,XX,9qh+ karyotype, which is considered a normal variant. The remaining 11 patients (27.5%) exhibited diverse chromosomal abnormalities. The most common abnormality was monosomy X (45,X), found in 4 patients (10%). Other abnormalities included sex reversal (46,XY in 1 patient, 2.5%), isochromosome (46,X,i(X)(q10) in 1 patient, 2.5%), and various structural X chromosome deletions (46,X,del(X)(p11.2), 46,X,del(X)(p22.1), and 46,X,del(X)(q24) each in 1 patient, 2.5% each). Two patients (5%) showed mosaicism, with one having mos 45,X\[22\]/46,Xi(X)(q.10)\[8\] and the other mos 45,X\[16\]/46,XY\[14\]. The study highlights the importance of cytogenetic analysis in the early diagnosis and management of PA. Karyotyping is an essential tool in identifying the underlying chromosomal abnormalities responsible for this condition. Early diagnosis and appropriate genetic counseling can significantly improve the quality of life for young girls affected by PA. The study also emphasizes the need to expand the availability of cytogenetic services, especially in developing regions like eastern India, to ensure timely and accurate diagnosis of PA cases.
Key Points
Here are the 6 key points from the research paper:
1. The study evaluated the types of chromosomal abnormalities found in 40 patients diagnosed with primary amenorrhea (PA) at the Department of Genetics in Nirnayan Healthcare, Kolkata, India.
2. Cytogenetic analysis of peripheral blood samples revealed that 29 out of the 40 PA patients (72.5%) had normal karyotypes, with 28 (70%) being 46,XX and 1 (2.5%) having a 46,XX,9qh+ karyotype, which is considered a normal variant.
3. The remaining 11 patients (27.5%) exhibited diverse chromosomal abnormalities, with the most common being monosomy X (45,X), found in 4 patients (10%). Other abnormalities included sex reversal (46,XY in 1 patient, 2.5%), isochromosome (46,X,i(X)(q10) in 1 patient, 2.5%), and various structural X chromosome deletions (46,X,del(X)(p11.2), 46,X,del(X)(p22.1), and 46,X,del(X)(q24) each in 1 patient, 2.5% each).
4. Two patients (5%) showed mosaicism, with one having mos 45,X\[22\]/46,Xi(X)(q.10)\[8\] and the other mos 45,X\[16\]/46,XY\[14\].
5. The study highlights the importance of cytogenetic analysis in the early diagnosis and management of PA, as karyotyping is an essential tool in identifying the underlying chromosomal abnormalities responsible for this condition.
6. The study emphasizes the need to expand the availability of cytogenetic services, especially in developing regions like eastern India, to ensure timely and accurate diagnosis of PA cases, which can significantly improve the quality of life for young girls affected by this condition.
Reference –
Byapti Banerjee, Atreyee Dutta, Sanchita Roy & Ajanta Halder (2024)Primary amenorrhoea - cytogenetic study in 40 Indian women, Journal of Obstetrics and Gynaecology, 44:1, 2348085, DOI: 10.1080/01443615.2024.2348085
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.